Accolade Inc
NASDAQ:ACCD
Accolade Inc
NASDAQ:ACCD
Price:
7.63 USD
-6.84%
Updated:
May 1, 2024
P/E
Price to Earnings
Price to Earnings
-4.8
Current
-6.4
Median
23.2
Industry
Higher
than median
Lower
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=-4.8
Market Cap
/
587.3m
Net Income
-122.7m
All Countries
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| US |
|
Accolade Inc
NASDAQ:ACCD
|
587.3m USD | -4.8 | |
| US |
|
Cigna Corp
NYSE:CI
|
104B USD | 20.1 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
96.9B EUR | 20 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
70.2B USD | 8.5 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.7B EUR | 45.6 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
16.9B USD | 38.9 | |
| DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15.8B EUR | -26.5 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
15.2B USD | 18 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.6B EUR | 23.3 | |
| US |
|
DaVita Inc
NYSE:DVA
|
12.3B USD | 17.9 | |
| US |
|
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | -18.6 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
-6.2
2-Years Forward
P/E
-6.6
3-Years Forward
P/E
-7.6
You don't have any saved screeners yet
